NCT06697054Active, not recruiting
Sentinel Lymph Node (SLN) Mapping with Charcoal Carbon Dye in Early Stage Cervical Cancer
Use of Charcoal Carbon Dye in Sentinel Lymph Node (SLN) Mapping in Early Stage Cervical Cancer
Source: ClinicalTrials.gov · Last updated 20 Nov 2024
Brief summary (registry, in English)
The aim of the present study is to compare the efficacy of charcoal carbon dye (CCD) in sentinel lymph node mapping compared to indocyanine green (ICG) mapping regarding detection rates, sensitivity, specificity, negative and positive predictive values in early stage cervical cancers (IA2 - IB2).
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 17 Nov 2024
- Start date
- 12 May 2024
- Primary completion date
- 12 May 2026
- Lead sponsor
- Istanbul University
- Diseases
- Cervical cancer
- NCT number
- NCT06697054
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 12 May 2024 to the primary completion date, 12 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1.Pervious radiotherapy 2.Age less than 18 3.Previous pelvic retroperitoneal surgery
Other
- \-
Who the study is looking for
- \-
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul University Med Fac Dept. of Obstet and Gynecol. Division of Gynecologic Oncology Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.